Biologics Safety Testing Market Research Report by Test Type (Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, and Residual Host Contaminant Detection Tests), by Application (Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Biologics Safety Testing Market is expected to grow from USD 3,823.75 Million in 2020 to USD 6,802.68 Million by the end of 2025.
2. The Global Biologics Safety Testing Market is expected to grow from EUR 3,352.74 Million in 2020 to EUR 5,964.72 Million by the end of 2025.
3. The Global Biologics Safety Testing Market is expected to grow from GBP 2,980.59 Million in 2020 to GBP 5,302.65 Million by the end of 2025.
4. The Global Biologics Safety Testing Market is expected to grow from JPY 408,091.78 Million in 2020 to JPY 726,018.84 Million by the end of 2025.
5. The Global Biologics Safety Testing Market is expected to grow from AUD 5,552.60 Million in 2020 to AUD 9,878.40 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Biologics Safety Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test Type, the Biologics Safety Testing Market studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Sterility Tests.
Based on Application, the Biologics Safety Testing Market studied across Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development.
Based on Geography, the Biologics Safety Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Safety Testing Market including Avance Biosciences Inc., Charles River Laboratories International, Inc., Cytovance Biologics, Inc., Eurofins Scientific Se, Lonza Group Ltd., Merck KGaA, Pace Analytical Services Inc., Sartorius AG, Source Bioscience, Thermo Fisher Scientific Inc., Toxikon Corporation, and Wuxi Apptec.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Safety Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biologics Safety Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Safety Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Safety Testing Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Safety Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Safety Testing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biologics Safety Testing Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Biologics Safety Testing Market is expected to grow from USD 3,823.75 Million in 2020 to USD 6,802.68 Million by the end of 2025.
2. The Global Biologics Safety Testing Market is expected to grow from EUR 3,352.74 Million in 2020 to EUR 5,964.72 Million by the end of 2025.
3. The Global Biologics Safety Testing Market is expected to grow from GBP 2,980.59 Million in 2020 to GBP 5,302.65 Million by the end of 2025.
4. The Global Biologics Safety Testing Market is expected to grow from JPY 408,091.78 Million in 2020 to JPY 726,018.84 Million by the end of 2025.
5. The Global Biologics Safety Testing Market is expected to grow from AUD 5,552.60 Million in 2020 to AUD 9,878.40 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Biologics Safety Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Test Type, the Biologics Safety Testing Market studied across Adventitious Agent Detection Tests, Bioburden Tests, Cell Line Authentication and Characterization Tests, Endotoxin Tests, Residual Host Contaminant Detection Tests, and Sterility Tests.
Based on Application, the Biologics Safety Testing Market studied across Blood and Blood-Related Products Testing, Cellular and Gene Therapy, Stem Cell Research, Tissue and Tissue-Related Products Testing, and Vaccine & Therapeutics Development.
Based on Geography, the Biologics Safety Testing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Safety Testing Market including Avance Biosciences Inc., Charles River Laboratories International, Inc., Cytovance Biologics, Inc., Eurofins Scientific Se, Lonza Group Ltd., Merck KGaA, Pace Analytical Services Inc., Sartorius AG, Source Bioscience, Thermo Fisher Scientific Inc., Toxikon Corporation, and Wuxi Apptec.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Safety Testing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biologics Safety Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Safety Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Safety Testing Market?
4. What is the competitive strategic window for opportunities in the Global Biologics Safety Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Biologics Safety Testing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Biologics Safety Testing Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE
6.1. Introduction
6.2. Adventitious Agent Detection Tests
6.3. Bioburden Tests
6.4. Cell Line Authentication and Characterization Tests
6.5. Endotoxin Tests
6.6. Residual Host Contaminant Detection Tests
6.7. Sterility Tests
7. GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION
7.1. Introduction
7.2. Blood and Blood-Related Products Testing
7.3. Cellular and Gene Therapy
7.4. Stem Cell Research
7.5. Tissue and Tissue-Related Products Testing
7.6. Vaccine & Therapeutics Development
8. AMERICAS BIOLOGICS SAFETY TESTING MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Avance Biosciences Inc.
12.2. Charles River Laboratories International, Inc.
12.3. Cytovance Biologics, Inc.
12.4. Eurofins Scientific Se
12.5. Lonza Group Ltd.
12.6. Merck KGaA
12.7. Pace Analytical Services Inc.
12.8. Sartorius AG
12.9. Source Bioscience
12.10. Thermo Fisher Scientific Inc.
12.11. Toxikon Corporation
12.12. Wuxi Apptec
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Test Type Outlook
3.4. Application Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TEST TYPE
6.1. Introduction
6.2. Adventitious Agent Detection Tests
6.3. Bioburden Tests
6.4. Cell Line Authentication and Characterization Tests
6.5. Endotoxin Tests
6.6. Residual Host Contaminant Detection Tests
6.7. Sterility Tests
7. GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY APPLICATION
7.1. Introduction
7.2. Blood and Blood-Related Products Testing
7.3. Cellular and Gene Therapy
7.4. Stem Cell Research
7.5. Tissue and Tissue-Related Products Testing
7.6. Vaccine & Therapeutics Development
8. AMERICAS BIOLOGICS SAFETY TESTING MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Avance Biosciences Inc.
12.2. Charles River Laboratories International, Inc.
12.3. Cytovance Biologics, Inc.
12.4. Eurofins Scientific Se
12.5. Lonza Group Ltd.
12.6. Merck KGaA
12.7. Pace Analytical Services Inc.
12.8. Sartorius AG
12.9. Source Bioscience
12.10. Thermo Fisher Scientific Inc.
12.11. Toxikon Corporation
12.12. Wuxi Apptec
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SCORES
TABLE 77. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RANKING
TABLE 80. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL BIOLOGICS SAFETY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL BIOLOGICS SAFETY TESTING MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL BIOLOGICS SAFETY TESTING MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. GLOBAL BIOLOGICS SAFETY TESTING MARKET: SCORES
TABLE 77. GLOBAL BIOLOGICS SAFETY TESTING MARKET: BUSINESS STRATEGY
TABLE 78. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PRODUCT SATISFACTION
TABLE 79. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RANKING
TABLE 80. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL BIOLOGICS SAFETY TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL BIOLOGICS SAFETY TESTING MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL BIOLOGICS SAFETY TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL BIOLOGICS SAFETY TESTING MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025
FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025
FIGURE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, 2020 VS 2025 (USD MILLION)
FIGURE 30. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 31. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 33. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 53. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GLOBAL BIOLOGICS SAFETY TESTING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL BIOLOGICS SAFETY TESTING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 66. GLOBAL BIOLOGICS SAFETY TESTING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TYPE
FIGURE 1. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS SAFETY TESTING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL BIOLOGICS SAFETY TESTING MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL BIOLOGICS SAFETY TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TEST TYPE, 2025
FIGURE 16. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ADVENTITIOUS AGENT DETECTION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BIOBURDEN TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELL LINE AUTHENTICATION AND CHARACTERIZATION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY ENDOTOXIN TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY RESIDUAL HOST CONTAMINANT DETECTION TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STERILITY TESTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 23. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY APPLICATION, 2025
FIGURE 25. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY BLOOD AND BLOOD-RELATED PRODUCTS TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY CELLULAR AND GENE THERAPY, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY STEM CELL RESEARCH, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY TISSUE AND TISSUE-RELATED PRODUCTS TESTING, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL BIOLOGICS SAFETY TESTING MARKET SIZE, BY VACCINE & THERAPEUTICS DEVELOPMENT, 2020 VS 2025 (USD MILLION)
FIGURE 30. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 31. AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 33. ARGENTINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. BRAZIL BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. CANADA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. MEXICO BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. UNITED STATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. AUSTRALIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. CHINA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. INDIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. INDONESIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. JAPAN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MALAYSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. PHILIPPINES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH KOREA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. THAILAND BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 53. FRANCE BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. GERMANY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. ITALY BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. NETHERLANDS BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. QATAR BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. RUSSIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SAUDI ARABIA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. SOUTH AFRICA BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. SPAIN BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. UNITED ARAB EMIRATES BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. UNITED KINGDOM BIOLOGICS SAFETY TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GLOBAL BIOLOGICS SAFETY TESTING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 65. GLOBAL BIOLOGICS SAFETY TESTING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 66. GLOBAL BIOLOGICS SAFETY TESTING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 67. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS SAFETY TESTING MARKET, BY TYPE
